# Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.

> **NCT01433120** · NA · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 58 (actual)

## Conditions studied

- Obesity
- Insulin Resistance

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus paracasei ssp paracasei F19
- **DIETARY_SUPPLEMENT:** Flax seed fibres
- **DIETARY_SUPPLEMENT:** Maltodextrin (Placebo)

## Key facts

- **NCT ID:** NCT01433120
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-06
- **Final completion:** 2013-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2014-06-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01433120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01433120, "Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01433120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*